Tag: AVE
Avecho Biotechnology raises $5.06m to develop pharmaceutical cannabinoid products
As the global medicinal cannabis space matures, Avecho Biotechnology (ASX: AVE) has secured more than $5 million via a heavily oversubscribed placement to advance its pharmaceutical cannabinoid progra...
Avecho strikes medicinal cannabis supply agreement with Tasmanian Alkaloids
Pharmaceutical company Avecho Biotechnology (ASX: AVE) has unveiled a supply agreement with Tasmanian Alkaloids in a bid to boost its natural medicinal cannabis products.
The deal terms state that ...
Avecho Biotechnology to source cannabinoids from US for advancement of TPM drug delivery platform
Australian-based Avecho Biotechnology (ASX: AVE) has signed a term sheet with US cannabinoid actives specialist Purisys LLC for the supply of synthetic, pharmaceutical-grade cannabidiol and dronabinol...